TANG CAPITAL MANAGEMENT LLC Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$435.9B
Holdings
8
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (8 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,047,250 | $197.8B | 45.38% | |
| 2 | HRTXHERON THERAPEUTICS INC | 5,818,541 | $150.9B | 34.63% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $43.9B | 10.08% | |
| 4 | —LA JOLLA PHARMACEUTICAL CO | 3,878,893 | $36.6B | 8.39% | |
| 5 | PBYIPUMA BIOTECHNOLOGY INC | 247,400 | $5.0B | 1.16% | |
| 6 | —OPHTHOTECH CORP | 600,000 | $720.0M | 0.17% | |
| 7 | PRTAPROTHENA CORP PLC | 47,610 | $490.0M | 0.11% | |
| 8 | EQEQUILLIUM INC | 47,343 | $386.0M | 0.09% |